Pancreatic Cancer Research

ResearcherJiaxing UniversityActive in the last 2 years

Bin Wu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3707-0056; OpenAlex author ID A5017942789. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper · 2025: 1 paper

Papers 3

  1. A novel tRNA-Derived Fragment, tRF-23-Z87HFK8SDZ inhibits malignant progression of pancreatic cancer through mediating IRS1. Co-author DOI 10.1016/j.abb.2025.110624↗
  2. Association between D-dimer levels and clinicopathological characteristics of pancreatic cancer and its role in prognosis: A systematic review and meta-analysi… Co-author DOI 10.1016/j.asjsur.2024.02.043↗
  3. CircZFR promotes pancreatic cancer progression through a novel circRNA-miRNA-mRNA pathway and stabilizing epithelial-mesenchymal transition protein. Co-author DOI 10.1016/j.cellsig.2023.110661↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhongcheng Zhou · 2 shared papers, 2023–2025 · strength 0.49
  2. Yiyu Shen · 2 shared papers, 2023–2025 · strength 0.49
  3. Liping Zheng · 1 shared paper, 2025 · strength 0.30
  4. Wei Wang · 1 shared paper, 2025 · strength 0.30
  5. Jie Wang · 1 shared paper, 2024 · strength 0.23
  6. Hui Cai · 1 shared paper, 2024 · strength 0.23
  7. Jing Wang · 1 shared paper, 2023 · strength 0.18
  8. Shaohan Wu · 1 shared paper, 2023 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.